Literature DB >> 21908498

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S Aebi1, T Davidson, G Gruber, F Cardoso.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21908498     DOI： 10.1093/annonc/mdr371

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  66 in total

1.  Significance of a positive sentinel lymph node biopsy in staging for distant metastasis in breast cancer: are current guidelines relevant?

Authors:  Tje Hubbard; C Ives
Journal:  Ann R Coll Surg Engl       Date:  2020-04-24       Impact factor: 1.891

2.  ¹⁸F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations.

Authors:  Alexandre Cochet; Inna Dygai-Cochet; Jean-Marc Riedinger; Olivier Humbert; Alina Berriolo-Riedinger; Michel Toubeau; Séverine Guiu; Charles Coutant; Bruno Coudert; Pierre Fumoleau; François Brunotte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-07       Impact factor: 9.236

Review 3.  The application of Oncotype DX in early-stage lymph-node-positive disease.

Authors:  Sarika Jain; William J Gradishar
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

4.  Does pregnancy-associated breast cancer imply a worse prognosis? A matched case-case study.

Authors:  Constantine Dimitrakakis; Flora Zagouri; Alexandra Tsigginou; Spyros Marinopoulos; Theodoros N Sergentanis; Antonis Keramopoulos; George C Zografos; Konstantina Ampela; Dimosthenis Mpaltas; Christos Papadimitriou; Meletios-Athanassios Dimopoulos; Aris Antsaklis
Journal:  Breast Care (Basel)       Date:  2013-06       Impact factor: 2.860

5.  Patient's Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer.

Authors:  Nadia Harbeck; Maria Blettner; Peyman Hadji; Christian Jackisch; Hans-Joachim Lück; Christine Windemuth-Kieselbach; Silke Zaun; Renate Haidinger; Doris Schmitt; Hilde Schulte; Ulrike Nitz; Rolf Kreienberg
Journal:  Breast Care (Basel)       Date:  2013-05       Impact factor: 2.860

6.  Prone Versus Supine Breast FDG-PET/CT for Assessing Locoregional Disease Distribution in Locally Advanced Breast Cancer.

Authors:  Richard G Abramson; Katrina F Lambert; Laurie B Jones-Jackson; Lori R Arlinghaus; Jason Williams; Vandana G Abramson; A Bapsi Chakravarthy; Thomas E Yankeelov
Journal:  Acad Radiol       Date:  2015-04-10       Impact factor: 3.173

7.  Therapeutic Application of Pharmacogenomics in Oncology.

Authors:  Yingqi Zhang; Seumsack Dennis Somtakoune; Christina Cheung; Mario Listiawan; Xiaodong Feng
Journal:  AAPS J       Date:  2016-05-13       Impact factor: 4.009

8.  Breast cancer treatment costs in younger, privately insured women.

Authors:  Benjamin T Allaire; Donatus U Ekwueme; Diana Poehler; Cheryll C Thomas; Gery P Guy; Sujha Subramanian; Justin G Trogdon
Journal:  Breast Cancer Res Treat       Date:  2017-04-21       Impact factor: 4.872

9.  Use of pegfilgrastim primary prophylaxis and risk of infection, by chemotherapy cycle and regimen, among patients with breast cancer or non-Hodgkin's lymphoma.

Authors:  Wendy J Langeberg; Conchitina C Siozon; John H Page; P K Morrow; Victoria M Chia
Journal:  Support Care Cancer       Date:  2014-03-21       Impact factor: 3.603

Review 10.  Current medical treatment of estrogen receptor-positive breast cancer.

Authors:  Franco Lumachi; Davide A Santeufemia; Stefano Mm Basso
Journal:  World J Biol Chem       Date:  2015-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.